Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
Associations' budget for overseas meeting to be monitored
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Aug 12, 2014 02:49:45
Pharmaceutical companies complain that they can’t monitor their financial support for the doctors who attend medical meetings in overseas countries as medical associations have an exclusive right to appoint their members for those meetings and use that fund.

An official of the Korean Pharmaceutical Manufacturers Association said, “We just got notices from medical associations about how they used the fund. We can’t control their budget.”

A product manager of a pharmaceutical company said, “The budget by medical associations should be monitored. The government’s joint investigation team should watch them over. Some doctors exaggerate their expenses.”

Other product manager pointed that multinational pharmaceutical companies invite Korean doctors to their own medical meetings held by the headquarters to increase their sales by offering those meetings. They can use those invitations as marketing tools.

Currently there is no regulation on overseas medical meetings. Critics say that the government should set up some rules to monitor the doctors’ medical meetings in overseas countries that can be used as a kind of rewards or rebates.
 
Reply 0
Name Password
Text
 
Popular News
 
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com